Moreover, increased galectin-3 expression in gastric cancer cells contributes to cellular unresponsiveness to interferon gamma (IFN-γ) by facilitating the AKT/GSK-3β/SHP2 signaling cascade [14]. Here, IFNG is linked to gastric cancer.